Last reviewed · How we verify
NCT06731114
"Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
NA trial testing Suboccipital muscle release in Cervicogenic Headache in 54 participants. Currently enrolling.
15 July 2025
Quick facts
| Lead sponsor | Foundation University Islamabad |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 15 July 2024 |
| Primary completion | 15 July 2025 |
| Estimated completion | 15 July 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Suboccipital muscle release
- Conventional physical therapy
- Sternocleidomastoid release
Conditions studied
- Cervicogenic Headache — all drugs for Cervicogenic Headache →
Sponsor
Foundation University Islamabad
Who can join
Adults 18 to 45, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomised control trial and the purpose of this study is to determine the "Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache".
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06731114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cervicogenic Headache
Currently open trials in the same condition.
- NCT07526025 — Comparative Effects Of Eye-Cervical Re-Education Exercises And Pressure Biofeedback Training Of Deep Cervical Flexors In · NA · recruiting
- NCT07366060 — Effectiveness of Third Occipital Nerve Pulsed Radiofrequency in Cervicogenic Headache · NA · recruiting
- NCT07354776 — Effect of Isometric Neck Exercises on Cervicogenic Headache, Cortisol, and BDNF in Adolescents With Smartphone Addiction · NA · recruiting
- NCT07347730 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Chronic Cervicogenic Headache · NA · recruiting
- NCT07508410 — Comparison of the Eficacy of Mulligan Mobilization and Myofascial Release in Patients With Cervicogenic Headache · NA · recruiting
Other Foundation University Islamabad trials
Trials by the same sponsor.
- NCT07485777 — Comparative Evaluation of Topical 30% Metformin and Kligman's Regimen in Women With Melasma · NA · not yet recruiting
- NCT07495748 — Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma · NA · not yet recruiting
- NCT07519174 — A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% i · NA · not yet recruiting
- NCT07526051 — Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome · NA · recruiting
- NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06731114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Foundation University Islamabad
- Last refreshed: 12 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06731114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing